This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

ADD2

Starting date:
December 17, 2009
Posting date:
January 18, 2010
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product withdrawal
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2010A31

Recalled products

  1. ADD2

Reason

ADD2 is an unauthorized NHP with non-approved claims for treating ADD (Attention Deficit Disorder) and the product is intended for use in children and teenagers 8 to 15 years old.

Depth of distribution

Wholesalers, distributors, retails and heath care practitioners - no exportation

Affected products

ADD2

DIN, NPN, DIN-HIM
No Market Authorization
Dosage form
  • Capsules
Strength

Fish oil 500 mg, fish lecithin 41.7mg

Lot or serial number

Box of 15 capsules

  • 837KOB

Box of 60 capsules

  • 1048HOA
  • 1048HOB
  • 1309HOA
  • 1783HOA
  • 712JOB
  • 776JOA
  • 776JOB
  • 1331JOA
  • 1331JOB
  • 269KOA
  • 269KOB
  • 323KOA
  • 323K0B
  • 837KOA

Box of 180 capsules

  • 1325KOA
  • 1326KOA
Companies
Recalling Firm
IRB Yves Ponroy Canada
2035 Onésime Gagnon ,
Lachine
H8T 3M5
Quebec
CANADA
Marketing Authorization Holder
IRB Yves Ponroy Canada
2035 Onésime Gagnon ,
Lachine
H8T 3M5
Quebec
CANADA

Date modified: